Tarenflurbil

Tarenflurbil
Clinical data
ATC code	none;
Legal status
Legal status	Withdrawn after Phase III;
Identifiers
	IUPAC name (R)-2-(3-Fluoro-4-phenylphenyl)propanoic acid;
CAS Number	51543-40-9 ;
PubChem CID	92337;
IUPHAR/BPS	7340;
ChemSpider	83361 ;
UNII	501W00OOWA;
PDB ligand	FLR (PDBe, RCSB PDB);
CompTox Dashboard (EPA)	DTXSID40199508 ;
ECHA InfoCard	100.052.041
Chemical and physical data
Formula	C15H13FO2
Molar mass	244.265 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Fc2cc(ccc2c1ccccc1)[C@H](C(=O)O)C;
	InChI InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/t10-/m1/s1 ; Key:SYTBZMRGLBWNTM-SNVBAGLBSA-N ;
	(what is this?) (verify)

Tarenflurbil, Flurizan or R-flurbiprofen, is a single enantiomer of the racemate NSAID flurbiprofen. For several years, research and trials for the drug were conducted by Myriad Genetics, to investigate its potential as a treatment for Alzheimer's disease; that investigation concluded in June 2008 when the company announced it would discontinue development of the compound.

Clinical data

ATC code	none
Legal status
Legal status	Withdrawn after Phase III
Identifiers
IUPAC name (R)-2-(3-Fluoro-4-phenylphenyl)propanoic acid
CAS Number	51543-40-9^N
PubChem CID	92337
IUPHAR/BPS	7340
ChemSpider	83361^N
UNII	501W00OOWA
PDB ligand	FLR (PDBe, RCSB PDB)
CompTox Dashboard (EPA)	DTXSID40199508
ECHA InfoCard	100.052.041
Chemical and physical data
Formula	C₁₅H₁₃FO₂
Molar mass	244.265 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES Fc2cc(ccc2c1ccccc1)[C@H](C(=O)O)C
InChI InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/t10-/m1/s1^N Key:SYTBZMRGLBWNTM-SNVBAGLBSA-N^N
^NY (what is this?) (verify)